Due to the evidence indicating the association of VDR, TAZ, YAP1, and CRB3 with demyelination process, we analyzed their gene expression in different groups of MS and healthy individuals to evaluate whether these molecules could contribute as biomarkers to familial and sporadic MS or become efficient, even in personalizing the treatment of the patients. This evidence concerns the gene CRB3 and myeloid sarcoma.